Product Information
ESOMEPRAZOLE DR 10 MG PACKET is a generic product labeled by Cipla USA Inc., priced at $4.9636 per EA under NDC 69097052734. Its NADAC has been published 324 times since Jul 22, 2020.
FDA first approved this application on Mar 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ESOMEPRAZOLE MAGNESIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097052734
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESOMEPRAZOLE MAGNESIUMApproval Type
Generic (ANDA)
FDA Application
ANDA211752FDA Approved
3/23/2020
TE Code
AB
On Market Since
3/24/2020
Pharmacological Classes
Price Statistics
The NADAC for ESOMEPRAZOLE DR 10 MG PACKET has been published 324 times since Jul 22, 2020, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9636 per EA |
|---|---|
| All-time high | $7.5669 (Aug 12, 2020) |
| All-time low | $4.9636 (Sep 23, 2026) |
| 52-week high | $7.0536 |
| 52-week low | $4.9636 |
| Median price | $6.8942 |
| Average price | $6.7909 |
| Largest weekly change | +12.1% (Nov 23, 2022) |
| Weeks tracked | 324 |
| Tracking since | Jul 22, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESOMEPRAZOLE MAGNESIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ESOMEPRAZOLE MAGNESIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESOMEPRAZOLE DR 10 MG PACKET?
The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE DR 10 MG PACKET, manufactured by Cipla USA Inc., is $4.9636 per EA (NDC 69097052734), effective Sep 30, 2026.
How has the price of ESOMEPRAZOLE DR 10 MG PACKET changed over time?
Over the history we have for it, the NADAC for ESOMEPRAZOLE DR 10 MG PACKET has declined 34.4%. It has been tracked across 324 weekly CMS publications since Jul 22, 2020.
What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE DR 10 MG PACKET?
Since Jul 22, 2020, the NADAC for ESOMEPRAZOLE DR 10 MG PACKET has ranged from a low of $4.9636 (Sep 23, 2026) to a high of $7.5669 (Aug 12, 2020), with a median of $6.8942 per EA.
Are there cheaper alternatives to ESOMEPRAZOLE DR 10 MG PACKET?
No other NADAC-published product currently shares the active ingredient and strength of ESOMEPRAZOLE DR 10 MG PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ESOMEPRAZOLE DR 10 MG PACKET?
ESOMEPRAZOLE DR 10 MG PACKET (NDC 69097052734) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.